X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis
Open Access
- 28 January 2005
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 78 (2) , 130-133
- https://doi.org/10.1002/ajh.20261
Abstract
X‐linked lymphoproliferative syndrome (XLP) is a rare, often fatal, primary immunodeficiency disease characterized by an abnormal response to Epstein‐Barr virus (EBV) infection. The gene responsible for XLP has been identified as SH2D1A/DSHP/SLAM‐associated protein (SAP). The major clinical manifestations include fulminant infectious mononucleosis, lymphoproliferative disorder, and dysgammaglobulinemia. Affected males uncommonly present with lymphocytic vasculitis in addition to aplastic anemia. In this study, we describe a Japanese XLP patient who presented with hypogammaglobulinemia following acute EBV‐induced infectious mononucleosis in the infancy and later had systemic lymphocytic vasculitis and hemophagocytic lymphohistiocytosis in the adulthood, which resolved by steroid pulse therapy. The patient's SAP gene was found to harbor a missense mutation (His8Asp), presumably resulting in defective expression of SAP in T cells. Biopsy specimens of lung and skin disclosed that CD8+ T cells predominantly infiltrated vascular vessels. However, immunohistochemical examination showed that EBV‐infected cells were not identifiable in the vessels. We propose that T‐cell‐mediated immune dysregulation in XLP can cause vasculitis by EBV infection‐unrelated mechanism. Am. J. Hematol. 78:130–133, 2005.Keywords
This publication has 16 references indexed in Scilit:
- Identification of anSH2D1A mutation in a hypogammaglobulinemic male patient with a diagnosis of common variable immunodeficiencyInternational Journal of Hematology, 2003
- Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detectionInternational Immunology, 2002
- Alterations of the X-linked lymphoproliferative disease geneSH2D1A in common variable immunodeficiency syndromeBlood, 2001
- SH2D1A mutations in Japanese males with severe Epstein-Barr virus–associated illnessesBlood, 2001
- Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency RegistryClinical and Experimental Immunology, 2000
- Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndromeProceedings of the National Academy of Sciences, 1998
- Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding geneNature Genetics, 1998
- The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAMNature, 1998
- X-Linked Lymphoproliferative Disease: Twenty-Five Years after the DiscoveryPediatric Research, 1995
- X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE)The Lancet, 1975